
ELISA versus ELISpot: Which assay is right for your research?
Published: July 29, 2025
10 minute read
Authored by: Lara Mentlein
Not sure whether to use ELISA or ELISpot? This guide breaks down the differences to help you select the most suitable assay for your project.
Introduction
In biomedical research, measuring proteins such as cytokines, antibodies, or growth factors is essential for understanding immune responses, disease progression, and treatment efficacy. Among the tools for this purpose are ELISA (Enzyme-Linked Immunosorbent Assay) and ELISpot (Enzyme-Linked ImmunoSpot).
While both techniques rely on antibody-based detection and enzyme-driven signal amplification, they serve different experimental goals. ELISA quantifies the amount of a specific protein in a sample, whereas ELISpot reveals how many individual cells are actively producing that protein.
So how do you decide which assay is best suited for your research? In this post, we’ll break down the key principles, applications, and differences between ELISA and ELISpot to help you choose the right tool for your next experiment.
What is ELISA?
ELISA (Enzyme-Linked Immunosorbent Assay) is one of the most widely used immunoassays for detecting and quantifying soluble proteins, such as cytokines, antibodies, and hormones, in biological fluids like serum, plasma, or cell culture supernatants. It works by capturing the target analyte using specific antibodies and generating a measurable signal, typically colorimetric, that correlates with the concentration of the analyte.
Renowned for its robustness, scalability, and quantitative output, ELISA is a go-to method in diagnostics, biomarker validation, and routine laboratory testing. While it doesn’t provide information on the cellular source of the analyte, ELISA excels in delivering accurate and reproducible concentration data across large sample sets.
ELISA types
The four main types of ELISA are direct, indirect, sandwich, and competitive ELISA.
- Direct ELISA employs an enzyme-labeled primary antibody. This format offers a straightforward and fast workflow but typically has lower sensitivity due to limited signal amplification.
- Indirect ELISA enhances sensitivity by introducing a two-step detection system involving a primary antibody followed by an enzyme-labeled secondary antibody. This setup allows for signal amplification but may introduce cross-reactivity, especially when using a secondary antibody raised against the species of the primary antibody.
- Sandwich ELISA is highly specific and ideal for detecting analytes in complex samples. It relies on two antibodies: a capture antibody, coated to the plate bottom, that immobilizes the target antigen and a detection antibody that binds a different epitope on the same antigen. While it requires well-matched antibody pairs, its high specificity and sensitivity make it our preferred method, especially for quantifying low-abundance analytes in complex matrices.
- Competitive ELISA is best suited for small molecules or antigens with limited epitopes. In this format, sample antigen competes with a labeled antigen for antibody binding. It provides high sensitivity but involves a more intricate setup and inverse signal readout (i.e., signal decreases with increasing antigen concentration).
When using ELISA to detect immunoglobulins, the assay design should be tailored to the specific research question. Learn more.
In summary, each ELISA format has its strengths and limitations. Choosing the right type depends on your experimental needs and available reagents.
How does it work?
In a sandwich ELISA, a high-binding plate is coated with a capture antibody specific to the target protein. After blocking to prevent non-specific binding, the sample and standard are added, allowing the target protein to bind to the capture antibody. A biotinylated detection antibody is then introduced, binding to a different epitope on the same protein. This is followed by a streptavidin-enzyme conjugate. Upon addition of a colorimetric substrate, the enzyme produces a visible signal proportional to the amount of protein present. The signal is measured using a plate reader and quantified by comparison to a standard curve.
ELISA readout
ELISA results are typically displayed using a standard curve that plots optical density (OD) values against known concentrations of the target protein. This curve is used to interpolate the concentrations of unknown samples, which are often shown in bar graphs to highlight differences between experimental groups. The data reflects the total amount of protein secreted in a sample, offering a quantitative, bulk-level view of cytokine or antibody production.
Representative 5-parameter ELISA standard curve
What is ELISpot?
ELISpot (Enzyme-Linked ImmunoSpot) is a highly sensitive immunoassay for counting cells secreting specific proteins, typically cytokines or antibodies. Unlike ELISA, which measures the overall concentration of analytes in a fluid sample, ELISpot provides a detailed snapshot of cellular immune responses at the single-cell level. It’s especially valuable in immunology research, where detecting rare antigen-specific T or B cells is critical, such as in vaccine development, autoimmune studies, or cancer immunotherapy monitoring.
How does it work?
In ELISpot, immune cells are added to a PVDF plate pre-coated with a capture antibody specific to the protein of interest. As the cells are stimulated, secreted protein is immediately captured around the cell by the immobilized antibody. After incubation, the cells are washed away, and a biotinylated detection antibody is added, followed by a streptavidin-enzyme conjugate. A precipitating substrate is then introduced, forming visible spots where individual cells secreted the target protein. Each spot represents a single responding cell and can be quantified using an ELISpot reader.
ELISpot readout
ELISpot results provide the number of protein-secreting cells. Each spot represents a cell that secreted the target protein during the assay. Representative images of wells show distinct spots that are counted with an ELISpot reader. These results are usually presented as bar graphs displaying spot-forming units (SFU) per million cells, providing single-cell resolution of immune activity.
T cell ELISpot: Human IFN-γ
B cell ELISpot: Human IgG and IgA
Comparison between ELISA and ELISpot
ELISA | ELISpot | |
Detects | Soluble proteins | Secreting cells |
Sample type | Plasma, serum, or supernatant | Live cells (e.g. PBMCs) |
Sensitivity | Moderate to high (depends on analyte and kit) | Very high |
Results | Protein concentration | Number of secreting cells |
Readout | Optical density (OD) read by a plate reader | Spot number read by an ELISpot/FluoroSpot reader |
Reagent requirements | Antibody pair, detection reagents, standard | Antibody pair, detection reagents |
Instrumentation | ELISA plate reader | ELISpot reader |
Multiplexing capacity | Limited. Possible with specific multiplex assays such as EYRAplex | Possible with FluoroSpot (uses different fluorophores) |
Throughput | High (96-well format and automation-friendly) | Moderate (manual cell handling is the typical bottleneck) |
Advantages | Well-established protocols, instrumentation widely available | High sensitivity, functional readout of rare responses |
Drawbacks | No information on number of cells responding | More labor-intensive, requires viable cells and specialized equipment |
Best used | Measuring protein levels in fluids | Identifying antigen-specific, cytokine-secreting cells |
When to choose ELISA
ELISA is your go-to assay when your goal is to quantify the concentration of a specific protein in solution. Whether you're working with serum, plasma, cell culture supernatants, or other fluids, ELISA provides a reliable and well-established platform for detecting soluble analytes.
Choose ELISA when:
- You want quantitative data. (ELISA results come in units like pg/ml or ng/ml.)
- You're analyzing secreted proteins, such as cytokines, antibodies, or hormones.
- Your experiment involves comparative analysis across multiple samples, such as treatment groups or time points.
- You need a high-throughput, scalable solution with compatibility for automation.
- You’re working with limited or no access to live immune cells, or simply don't need cellular resolution.
Typical applications include:
- Profiling cytokine secretion in response to stimuli.
- Measuring antibody titers in infection or vaccine studies.
- Monitoring biomarkers in clinical samples.
- Validating protein expression levels in recombinant systems.
When to choose ELISpot
ELISpot is the method of choice when you need to evaluate functional immune responses at the single-cell level. It’s designed to detect and count individual cells that secrete a target protein, offering unmatched sensitivity for identifying rare responder cells.
Choose ELISpot when:
- You want to measure the number of protein-secreting cells (e.g., IFN-γ–producing T cells).
- You need to assess cell-mediated immunity, particularly in response to antigens or pathogens.
- Your study involves vaccine development, cancer immunotherapy, or T cell monitoring.
- You're working with PBMCs, isolated immune cells, or splenocytes from human or animal sources.
- You require high sensitivity.
Typical applications include:
- Monitoring T cell responses in vaccine trials.
- Evaluating immune activation in infectious disease or oncology studies.
- Tracking B cell antibody production at the single-cell level.
- Detecting rare immune events not visible in bulk protein analysis.
Practical consideration
When deciding between ELISA and ELISpot, it's also important to factor in practical aspects of your experiment:
- Sample type
ELISA requires a liquid sample (e.g., serum, plasma, or supernatant), making it a good fit when viable cells are unavailable. ELISpot, on the other hand, needs freshly isolated or properly frozen immune cells, which may limit its use depending on sample access. - Sensitivity
ELISpot offers high resolution and can detect rare antigen-specific responses. ELISA is less sensitive but provides robust concentration data for proteins that are abundantly secreted. - Readout equipment
ELISA results are typically read on a standard plate reader, which is widely available in most labs. ELISpot requires a specialized plate reader and analysis software to detect and count individual spots (cells). - Assay complexity
ELISA protocols tend to be simpler, particularly when using pre-coated plates. ELISpot requires careful cell handling, making it slightly more technically demanding. - Results
ELISA gives you a quantitative concentration (e.g., pg/ml), while ELISpot gives you a number of secreting cells (e.g., SFU per 10⁶ cells). Think about which type of data best supports your experimental goals.
Using ELISA and ELISpot together
While ELISA and ELISpot each offer unique strengths, they’re highly complementary when used together. For example, ELISpot can tell you how many cells are producing a certain cytokine, while ELISA tells you how much of that cytokine ends up in the supernatant. By pairing these assays, you can build a more complete picture of the immune response.
Here are a few examples where combining both assays makes sense:
- Vaccine development: Use ELISpot to detect antigen-specific T cell responses, and ELISA to quantify antibody titers or secreted cytokines in serum.
- Immunotherapy monitoring: Use ELISpot to track functional immune activation at the cellular level, and ELISA to monitor systemic cytokine release.
- Biomarker discovery: Use ELISpot to identify rare immune responders, and ELISA to confirm downstream protein levels in fluids.
Conclusion
Both ELISA and ELISpot are powerful tools for measuring immune responses. ELISA offers a reliable method for quantifying total protein levels in fluid samples, while ELISpot provides the sensitivity and resolution needed to detect individual cytokine-secreting cells. Your choice of assay may depend on various factors, such as your research question or practical considerations like sample availability. However, rather than choosing one over the other, many researchers find that combining both assays offers deeper insight into the immune response.
References to assay comparison studies
Studies comparing ELISpot and ELISA:
- Tanguay et Killion, Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells, Lymphokine Cytokine Res 1994
- Kabilan et al., Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen, Infect Immun 1990
In-house study comparing ELISpot and ELISA:
Studies showing superior sensitivity for ELISpot over intracellular cytokine staining in flow-based assays:
- Villemonteix et al., Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19, Immun Inflamm Dis 2022
- Chauvat et al., Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans, Hum Vaccin Immunother 2014